Condition: Asthma · Sponsor: GlaxoSmithKline
Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.
This description comes directly from the study's public registry record.
US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com
EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | Brooksville, Florida, United States | Recruiting |
| GSK Investigational Site | Plantation, Florida, United States | Recruiting |
| GSK Investigational Site | Kansas City, Kansas, United States | Recruiting |
| GSK Investigational Site | St Louis, Missouri, United States | Recruiting |
| GSK Investigational Site | New Brunswick, New Jersey, United States | Recruiting |
| GSK Investigational Site | New York, New York, United States | Recruiting |
| GSK Investigational Site | DuBois, Pennsylvania, United States | Recruiting |
| GSK Investigational Site | Philadelphia, Pennsylvania, United States | Recruiting |
| GSK Investigational Site | McKinney, Texas, United States | Completed |
| GSK Investigational Site | Mechelen, Belgium | Recruiting |
| GSK Investigational Site | Namur, Belgium | Recruiting |
| GSK Investigational Site | Ajax, Ontario, Canada | Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06979323